Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 8
2004 2
2005 3
2006 2
2007 2
2008 3
2009 9
2010 3
2011 2
2012 2
2013 3
2014 3
2015 13
2016 11
2017 7
2018 8
2019 8
2020 7
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 33144483

87 results

Results by year

Filters applied: . Clear all
Page 1
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.
Holmes FA, Jones SE, O'Shaughnessy J, Vukelja S, George T, Savin M, Richards D, Glaspy J, Meza L, Cohen G, Dhami M, Budman DR, Hackett J, Brassard M, Yang BB, Liang BC. Holmes FA, et al. Ann Oncol. 2002 Jun;13(6):903-9. doi: 10.1093/annonc/mdf130. Ann Oncol. 2002. PMID: 12123336 Free article. Clinical Trial.
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy.
Billingsley CC, Jacobson SN, Crafton SM, Crim AK, Li Q, Hade EM, Cohn DE, Fowler JM, Copeland LJ, Salani R, Backes FJ, O'Malley DM. Billingsley CC, et al. Int J Gynecol Cancer. 2015 Sep;25(7):1331-6. doi: 10.1097/IGC.0000000000000487. Int J Gynecol Cancer. 2015. PMID: 26067861
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.
Cerchione C, De Renzo A, Di Perna M, Della Pepa R, Pugliese N, Catalano L, Pane F, Picardi M. Cerchione C, et al. Support Care Cancer. 2017 Mar;25(3):839-845. doi: 10.1007/s00520-016-3468-8. Epub 2016 Nov 3. Support Care Cancer. 2017. PMID: 27812763 Free PMC article.
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.
Schwartzberg LS, Bhat G, Peguero J, Agajanian R, Bharadwaj JS, Restrepo A, Hlalah O, Mehmi I, Chawla S, Hasal SJ, Yang Z, Cobb PW. Schwartzberg LS, et al. Oncologist. 2020 Aug;25(8):e1233-e1241. doi: 10.1634/theoncologist.2020-0105. Epub 2020 Jun 16. Oncologist. 2020. PMID: 32476162 Free PMC article. Clinical Trial.
87 results